Expression of the telomerase catalytic subunit, hTERT, induces resistance to transforming growth factor β growth inhibition in p16INK4A(−) human mammary …

MR Stampfer, J Garbe, G Levine… - Proceedings of the …, 2001 - National Acad Sciences
MR Stampfer, J Garbe, G Levine, S Lichtsteiner, AP Vasserot, P Yaswen
Proceedings of the National Academy of Sciences, 2001National Acad Sciences
Failures to arrest growth in response to senescence or transforming growth factor β (TGF-β)
are key derangements associated with carcinoma progression. We report that activation of
telomerase activity may overcome both inhibitory pathways. Ectopic expression of the
human telomerase catalytic subunit, hTERT, in cultured human mammary epithelial cells
(HMEC) lacking both telomerase activity and p16INK4A resulted in gaining the ability to
maintain indefinite growth in the absence and presence of TGF-β. The ability to maintain …
Failures to arrest growth in response to senescence or transforming growth factor β (TGF-β) are key derangements associated with carcinoma progression. We report that activation of telomerase activity may overcome both inhibitory pathways. Ectopic expression of the human telomerase catalytic subunit, hTERT, in cultured human mammary epithelial cells (HMEC) lacking both telomerase activity and p16INK4A resulted in gaining the ability to maintain indefinite growth in the absence and presence of TGF-β. The ability to maintain growth in TGF-β was independent of telomere length and required catalytically active telomerase capable of telomere maintenance in vivo. The capacity of ectopic hTERT to induce TGF-β resistance may explain our previously described gain of TGF-β resistance after reactivation of endogenous telomerase activity in rare carcinogen-treated HMEC. In those HMEC that overcame senescence, both telomerase activity and TGF-β resistance were acquired gradually during a process we have termed conversion. This effect of hTERT may model a key change occurring during in vivo human breast carcinogenesis.
National Acad Sciences